Lineage Cell Therapeutics Inc
(FRA:BT3)
€
1.036
(0%)
Market Cap: 256.13 Mil
Enterprise Value: 210.33 Mil
PE Ratio: 0
PB Ratio: 5.42
GF Score: 78/100 Lineage Cell Therapeutics Inc (FRA:BT3) Transcripts
- 1